Thomas Marron
Clinical trials sponsored by Thomas Marron, explained in plain language.
-
Could an old HIV drug help fight cancer?
Disease control OngoingThis study tests whether adding lamivudine, an HIV drug, to standard immunotherapy can help shrink or control advanced solid tumors that have stopped responding to treatment. About 12 to 24 adults with various solid cancers will receive lamivudine alongside their current immunoth…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could two extra drugs revive immunotherapy for tough lung cancers?
Disease control OngoingThis early-phase trial is testing whether adding two drugs, dupilumab and anakinra, to standard immunotherapy can help people with advanced non-small cell lung cancer whose cancer has stopped responding to treatment. About 33 participants will receive the combination to see if it…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC